BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22269984)

  • 21. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The APOE ɛ4 allele modulates brain white matter integrity in healthy adults.
    Heise V; Filippini N; Ebmeier KP; Mackay CE
    Mol Psychiatry; 2011 Sep; 16(9):908-16. PubMed ID: 20820167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
    Pesaresi M; Batelli S; Prato F; Polito L; Lovati C; Scarpini E; Quadri P; Mariani C; Albani D; Forloni G
    Neurobiol Dis; 2007 Mar; 25(3):609-13. PubMed ID: 17174555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An observational study on the influence of the APOE-epsilon4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease.
    Zappasodi F; Salustri C; Babiloni C; Cassetta E; Del Percio C; Ercolani M; Rossini PM; Squitti R
    Brain Res; 2008 Jun; 1215():183-9. PubMed ID: 18486114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter changes in dementia with Lewy bodies and Alzheimer's disease: a tractography-based study.
    Kiuchi K; Morikawa M; Taoka T; Kitamura S; Nagashima T; Makinodan M; Nakagawa K; Fukusumi M; Ikeshita K; Inoue M; Kichikawa K; Kishimoto T
    J Psychiatr Res; 2011 Aug; 45(8):1095-100. PubMed ID: 21315376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activity.
    de Waal H; Stam CJ; de Haan W; van Straaten EC; Blankenstein MA; Scheltens P; van der Flier WM
    Neurobiol Aging; 2013 Sep; 34(9):2158-63. PubMed ID: 23587637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
    Choi SH; Kim SY; Na HR; Kim BK; Yang DW; Kwon JC; Park MY
    Dement Geriatr Cogn Disord; 2008; 25(5):445-50. PubMed ID: 18401173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivariate network analysis of fiber tract integrity in Alzheimer's disease.
    Teipel SJ; Stahl R; Dietrich O; Schoenberg SO; Perneczky R; Bokde AL; Reiser MF; Möller HJ; Hampel H
    Neuroimage; 2007 Feb; 34(3):985-95. PubMed ID: 17166745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early and late onset Alzheimer's disease patients have distinct patterns of white matter damage.
    Canu E; Frisoni GB; Agosta F; Pievani M; Bonetti M; Filippi M
    Neurobiol Aging; 2012 Jun; 33(6):1023-33. PubMed ID: 21074899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Voxel-based detection of white matter abnormalities in mild Alzheimer disease.
    Xie S; Xiao JX; Gong GL; Zang YF; Wang YH; Wu HK; Jiang XX
    Neurology; 2006 Jun; 66(12):1845-9. PubMed ID: 16801648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.
    Fellgiebel A; Wille P; Müller MJ; Winterer G; Scheurich A; Vucurevic G; Schmidt LG; Stoeter P
    Dement Geriatr Cogn Disord; 2004; 18(1):101-8. PubMed ID: 15087585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E homozygous ε4 allele status: Effects on cortical structure and white matter integrity in a young to mid-age sample.
    Goltermann J; Repple J; Redlich R; Dohm K; Flint C; Grotegerd D; Waltemate L; Lemke H; Fingas SM; Meinert S; Enneking V; Hahn T; Bauer J; Schmitt S; Meller T; Stein F; Brosch K; Steinsträter O; Jansen A; Krug A; Nenadić I; Baune BT; Rietschel M; Witt S; Forstner AJ; Nöthen M; Johnen A; Alferink J; Kircher T; Dannlowski U; Opel N
    Eur Neuropsychopharmacol; 2021 May; 46():93-104. PubMed ID: 33648793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation on brain gray matter activity and white matter integrity by APOE ε4 risk gene in cognitively intact elderly: A multimodal neuroimaging study.
    Cai S; Jiang Y; Wang Y; Wu X; Ren J; Lee MS; Lee S; Huang L
    Behav Brain Res; 2017 Mar; 322(Pt A):100-109. PubMed ID: 28108320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study.
    Teipel SJ; Meindl T; Wagner M; Stieltjes B; Reuter S; Hauenstein KH; Filippi M; Ernemann U; Reiser MF; Hampel H
    J Alzheimers Dis; 2010; 22(2):507-22. PubMed ID: 20847446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.
    Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W
    J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.